SC, G., EM, Y., EJ, L., BR, B., MS, S., M, D., . . . K, R. R. (2013). Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin. Alimentary pharmacology & therapeutics, 38(1), 16. https://doi.org/10.1111/apt.12342
Chicago Style (17th ed.) CitationSC, Gordon, et al. "Adherence to Assigned Dosing Regimen and Sustained Virological Response Among Chronic Hepatitis C Genotype 1 Patients Treated with Boceprevir Plus Peginterferon Alfa-2b/ribavirin." Alimentary Pharmacology & Therapeutics 38, no. 1 (2013): 16. https://doi.org/10.1111/apt.12342.
MLA (9th ed.) CitationSC, Gordon, et al. "Adherence to Assigned Dosing Regimen and Sustained Virological Response Among Chronic Hepatitis C Genotype 1 Patients Treated with Boceprevir Plus Peginterferon Alfa-2b/ribavirin." Alimentary Pharmacology & Therapeutics, vol. 38, no. 1, 2013, p. 16, https://doi.org/10.1111/apt.12342.